Abstract: A series of 3-mercapto-1,2,4-triazole-pyrrole hybrids was designed as antimycobacterial agents by employing 5-(4-(1 H -pyrrol-1-yl)phenyl)-4 H -1,2,4-triazole-3-thiol as the scaffold onto which several types of moieties were introduced in the triazole ring at N-4 and N-2 and as substituents of the mercapto function. The aforementioned moieties are an allyl or a phenyl moiety at N-4; an aminomethyl group at N-2; or methyl, substituted benzyl, ethoxycarbonylmethyl, or substituted phenacyl at sulfur. Investigation of the compounds in the resulting library as growth inhibitors of Mycobacterium smegmatis showed that their minimum inhibitory concentration was higher than 64 mg/L.
Introduction
Tuberculosis is a major contagious disease that affects tens of millions of people, especially in poor countries in Africa and Southeast Asia, and, with approximately 1.7 million deaths in 2016, is the leading cause of death from infectious disease worldwide, ranking above HIV/AIDS, according to the WHO Global Tuberculosis Report 2017 (www.who.int/entity/tb/publications/global_report/gtbr2017_main_text.pdf). Despite the fact that several drugs are available for keeping tuberculosis under control or even curing it, the rate of successful treatments in Directly Observed Treatment Short-course (DOTS), the multidrug therapy program developed by the World Health Organization, remains in the low eighties, as stated in the same WHO Global Tuberculosis Report 2017. The most common cause of treatment failure using first-line antitubercular drugs in DOTS (isoniazid, rifampicin, pyrazinamide, and ethambutol) is often poor patient compliance due to the lengthy period of treatment (6 months) and sometimes to the side effects (e.g., toxicity of isoniazid) of the drugs used in therapy. The consequences associated with this failure include the emergence of multidrug-resistant strains of M. tuberculosis leading to high rates of recurrence, appearance of extensively drug-resistant strains, and eventually mortality. The discovery of novel drugs that could improve treatment of both sensitive and resistant tuberculosis is highly needed, and several drug candidates have been developed and have reached early stages in clinical trials in recent years.
1−4
Chemical modification of a known antituberculosis drug, target-based drug design, combinatorial synthesis, in silico design, and high-throughput screening represent a few of the approaches that are commonly employed in the discovery of novel drug candidates for treatment of tuberculosis. Among them, high-throughput screening is essential for the identification of novel lead compounds, preferably acting on hitherto unknown tar- Program has been established specifically to provide reliable screening of chemical libraries with the view to identify novel scaffolds of interest, and make the data publicly accessible to the tuberculosis research community.
5
As a part of this program, a chemical library containing 100,997 compounds, obtained from the ChemBridge Corporation and selected for diversity and drug-likeness using the Lipinski criteria, has been screened against M. tuberculosis strain H 37 Rv using the microdilution Alamar blue assay adapted for high-throughput screening in 384-well plate format. 6 The screening uncovered several scaffolds and clusters of active compounds, which appear to be novel classes of compounds that exhibit significant antitubercular activity, and may therefore serve as leads in antitubercular drug discovery and development. One of these clusters of compounds with antitubercular activity included a small number of S-alkylated derivatives of 3-mercapto-1,2,4-triazole (particularly esters or amides of acetic acid), which had IC 90 values lower than 5.0 µg/mL This finding is confirmed by the numerous literature examples of mercaptotriazole derivatives that have been recently successfully investigated as antimycobacterial agents.
7−12 On the other hand, pyrrole has emerged as a privileged scaffold in the design of Figure 1 ).
Molecular hybridization is a rational strategy in drug design that has been extensively employed in recent years. 28, 29 This approach identifies two or more structural features that are pharmacologically relevant for the desired biological activity in different molecules, and subsequently develops hybrid molecules by merging these pharmacophores through an adequate linker. In the field of antitubercular agents, this concept has been successfully applied to the design of hybrid molecules derived from analogues of BM212 and either antibacterial oxazolidinones 30 or antitubercular adamantane-diamine SQ109. 31 In the current study, the previously identified 3-mercapto-1,2,4-triazole and pyrrole pharmacophores were combined through a 1,4-phenylene linker to provide a hybrid scaffold 13 ( Figure 2 ) that could be subsequently modified at the marked reactive sites using suitable chemistry. To the best of our knowledge, compounds 14 (R = H or CH 3 ) (Figure 2 ) are the only candidates based on scaffold 13 that have been evaluated so far against M. tuberculosis H 37 Rv, and these investigations led to mixed results. Thus, the minimum inhibitory concentration (MIC) was 62.5 µg/mL when R = H, 32 whereas when R = CH 3 MIC was as low as 4 µ g/mL. 33 The present study expands the structural diversity of such valuable candidates for antimycobacterial testing by creating a small library of compounds obtained through chemical modifications of the mercaptotriazole fragment of scaffold 13. Figure 2 . Structure of the hybrid scaffold 13 employed in the development of the novel potential antitubercular agents in this paper and the general structure of candidates 14 featuring this scaffold that have been evaluated as tuberculostatics so far.
Results and discussion

Design
Depending on the substituent at positions 2 and 5 of the pyrrole ring (either hydrogen or methyl), the candidates in the present study belong to two subsets of structures. In addition, the compounds that were designed and synthesized for this small library feature either a phenyl or an allyl moiety at N-4 of the triazole ring. Starting from these four parent compounds 23-26 (Figure 3 ), the remaining members of the library were designed to generate a broader chemical diversity through chemical modifications of the mercaptotriazole fragment of scaffold 13 either at the sulfur atom or at N-1 of the triazole ring. Because the S-alkylated mercaptotriazoles that have been identified as a result of screening of the ChemBridge Corporation library for antitubercular hit compounds 6 have either an acetic acid ester or an acetamide moiety attached to the sulfur atom, this particular modification is well represented in the library through compounds 27-30. Further S-alkylation of the parent mercaptotriazoles was performed with the view to investigate the effect on the antitubercular activity of the replacement of the carbethoxy group in some of esters 27-30. Thus, formal replacement of the carbethoxy group with hydrogen led to compound 31, while candidates 32 and 33 were designed by replacing the carbethoxy group with aryl moieties. In addition, in order to evaluate the effect that the replacement of the ethoxy group in esters 29 and 30 with an aryl moiety has on antitubercular activity, two other S-alkylated mercaptotriazoles, namely compounds 34 and 35, were included in this library. Finally, in order to glean an insight into the significance upon antitubercular activity of modification of mercaptotriazole in scaffold 13 at different reactive sites, substitution of this fragment with an aminomethyl group at N-2 was also undertaken to provide candidates 36-40.
Chemistry
The synthesis of the candidates in this library employs methyl 4-aminobenzoate and either 2,5-dimethoxytetrahydrofuran or hexane-2,5-dione as starting materials to generate intermediate esters The structure of the synthesized compounds was analyzed using NMR spectroscopy. Pyrrole ring closure was confirmed through the presence of signals in the 1 H NMR spectra of compounds 15 and 16 that can be attributed to protons in the pyrrole ring (6.39 and 7.16 ppm for 15, and 5.84 ppm for 16). The formation of the hydrazides 17 and 18 was established through the presence in their 1 H NMR spectra of a singlet at approximately 4.5 ppm integrating for two protons and of a second singlet at approximately 9.8 ppm integrating for one proton; the integral value of both signals decreases significantly upon addition of deuterated water to the NMR sample, which is indicative of the presence of mobile protons in the structure of compounds 17 and 18. Conversion of hydrazides 17 and 18 into thiosemicarbazides 19-22 can be correlated with the presence of three singlets integrating for one proton in the 8-10.7 ppm range of each proton spectrum of intermediates 19-22; these singlets are associated with the three exchangeable protons discernible in the structure of thiosemicarbazides 19-22 owing to their facile replacement by deuterium following the addition of deuterated water to the NMR sample. Evidence for the successful ring closure of thiosemicarbazides 19-22 to mercaptotriazoles 23-26 is provided by the absence in the proton spectra of these compounds of the three singlets noticed in the spectra of thiosemicarbazides, whereas a novel singlet that is located above 14 ppm, integrates for one proton, and is exchangeable with deuterium can be attributed to the proton at N-1 in the triazolethione tautomer of compounds 23-26. The outcome of the S-alkylation of these mercaptotriazoles with various reactive halogenated derivatives can be also evaluated using NMR spectroscopy by showing the particular spectral features that can be associated with the appendages grafted onto the mercaptotriazole fragment. Thus, the presence of an acetic acid ester moiety in the structure of candidates 27-30 is supported by the identification of a triplet in the 1.1-1.2 ppm range, a quartet centered at approximately 4.2 ppm and a singlet close to 4.1 ppm corresponding to methyl and methylene protons on the ester function, and to methylene protons directly linked to sulfur, respectively.
A sharp singlet at 2.6 ppm in the 1 H NMR spectrum of methyl thioether 31 confirms the S-methylation of mercaptotriazole 24, whereas the singlet at approximately 4.4 ppm in the proton spectra of benzyl thioethers 32 and 33 is indicative of the S-benzylation of mercaptotriazole-pyrrole hybrids 25 and 26. The attachment of a phenacyl moiety at the sulfur in mercaptotriazole-pyrrole hybrids 23 and 26 is demonstrated by the presence of a singlet at approximately 4.7-5.0 ppm in the proton spectra of compounds 34 and 35. As far as the aminomethyl derivatives 36-40 are concerned, the correct number and integration of the signals corresponding to the protons in the amine moiety in each case, corroborated with the presence of a singlet at 5.2-5.4 ppm in the 1 H NMR spectrum of these compounds, which is associated with the protons of the methylene group adjacent to N-2 of the triazole ring, provide sufficient experimental evidence to validate the formation of these Mannich bases.
Biological evaluation
The antimycobacterial activity of compounds 23-40 was evaluated against Mycobacterium smegmatis using the and the experimental evidence was interpreted as a lack of any significant activity against M. smegmatis type strain for the candidates under evaluation.
Conclusions
Based on a scaffold that incorporates two fragments, namely pyrrole and 3-mercapto-1,2,4-triazole, which have been previously identified as pharmacophores in compounds with antimycobacterial activity, a library of candidates was designed as potential antitubercular agents using the hybridization approach. Aiming at molecular diversity within the library, three active sites in the mercaptotriazole fragment of the scaffold were chemically modified with structurally diverse moieties. The candidates in the library were screened against M.
smegmatis, and their MICs were found to be higher than 64 mg/L. Because the compounds in the collection are practically devoid of any useful antimycobacterial activity in spite of the diverse substitution pattern within the library, it appears that the core structure in the mercaptotriazole-pyrrole hybrids is largely responsible for the lack of biological activity in these series of candidates. Therefore, the association between 3-mercapto-1,2,4-triazole and pyrrole pharmacophores through a 1,4-phenylene linker does not seem to be conducive to the manifestation of antimycobacterial activity as it was rationalized in the working hypothesis presented in the Introduction.
Experimental
Materials and methods
All chemical reagents and solvents were obtained from Sigma-Aldrich (Schnelldorf, Germany). Mueller Hinton broth was provided by Merck (Darmstadt, Germany). Standard antibiotic rifampicin was a product of SigmaAldrich (Schnelldorf, Germany). Column chromatography was performed on silica gel (230-400 mesh, 60 Å) (Sigma-Aldrich, Schnelldorf, Germany). Analytical TLC was performed on Merck glass-backed precoated silica gel 60 F254 plates, and the compounds were visualized by UV illumination (254 nm). Melting points were recorded on a Mel-Temp II apparatus and are uncorrected. NMR spectra were recorded on a Bruker Avance 400 MHz spectrometer. The signals from residual protons in deuterated solvents were used as internal standards for the 1 H NMR spectra. Chemical shifts for the carbon atoms are given relative to CDCl 3 (δ = 77.16 ppm)
or DMSO-d 6 ( δ = 39.52 ppm). Elemental analysis was conducted on a PerkinElmer 2400 Series II CHNS/O system.
Synthesis
Methyl 4-(1H -pyrrol-1-yl)benzoate (15)
A mixture of methyl 4-aminobenzoate (1.51 g, 10 mmol) and 2,5-dimethoxytetrahydrofuran (1.36 g, 10 mmol)
in glacial acetic acid (5 mL) was heated at reflux temperature for 1 h. The dark brown solution was diluted with water (50 mL) while still hot, and then allowed to cool to room temperature. 
Methyl 4-(2,5-dimethyl-1H -pyrrol-1-yl)benzoate (16)
A solution of methyl 4-aminobenzoate (3.02 g, 20 mmol), 2,5-hexanedione (2.28 g, 20 mmol), and glacial acetic acid (0.5 mL) in 96% ethanol (20 mL) was heated at reflux temperature for 6 h, and then the solvent was partially removed under reduced pressure. 
4-(1H -Pyrrol-1-yl)benzoic acid hydrazide (17)
A solution of methyl 4-(1 H -pyrrol-1-yl)benzoate (15) 
4-Phenyl-1-[4-(1H -pyrrol-1-yl)benzoyl]thiosemicarbazide (20)
This compound was obtained from 4-(1 H -pyrrol-1-yl)benzoic acid hydrazide (17) 
4-Allyl-1-[4-(2,5-dimethyl-1H -pyrrol-1-yl)benzoyl]thiosemicarbazide (21)
This compound was obtained from 4-(2,5-dimethyl-1H -pyrrol-1-yl)benzoic acid hydrazide (18) 
1-[4-(2,5-Dimethyl-1H -pyrrol-1-yl)benzoyl]-4-phenylthiosemicarbazide (22)
General procedure for the synthesis of mercaptotriazoles 23-26
A mixture of thiosemicarbazide 19-22 (3 mmol) and KOH (396 mg, 6 mmol, 85% purity) in water (30 mL) was refluxed for 3 h, and then the cooled solution was brought to pH 6 by dropwise addition of 10% acetic acid. The separated solid was filtered, washed thoroughly with water, and air dried. 
4-Allyl-3-[4-(1H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (23)
This compound was obtained from 4-allyl-1-[4-(1 H -pyrrol-1-yl)benzoyl]thiosemicarbazide (19
4-Phenyl-3-[4-(1H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (24)
This compound was obtained from 4-phenyl-1-[4-(1H -pyrrol-1-yl)benzoyl]thiosemicarbazide (20 
4-Allyl-3-[4-(2,5-dimethyl-1H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (25)
This compound was obtained from 4-allyl- 
General procedure for the synthesis of esters 27 and 28
To the solution obtained from mercaptotriazoles 23 or 24 (1 mmol) and KOH (66 mg, 1 mmol, 85% purity) in 96% ethanol (10 mL) was added ethyl bromoacetate (167 mg, 1 mmol) and the mixture was heated at reflux temperature for 1 h. The cooled reaction mixture was gradually diluted with water (20 mL) and the solid that separated was filtered, washed with a mixture of ethanol-water (10 mL, 1:2 v/v), and air dried.
Ethyl 2-{{5-[4-(1H -pyrrol-1-yl)phenyl]-4-allyl-4H -1,2,4-triazol-3-yl}thio}acetate (27)
This compound was obtained from 4-allyl-3-[4-(1 H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (23) . The solid was dissolved in refluxing 96% ethanol (5 mL), the solution was cooled at approximately 40°C, and then it was diluted with n -hexane (7 mL) and refrigerated overnight. 
Ethyl 2-{{5-[4-(1H -pyrrol-1-yl)phenyl]-4-phenyl-4H -1,2,4-triazol-3-yl}thio}acetate (28)
This compound was obtained from 4-phenyl-3-[4-(1H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (24 
General procedure for the synthesis of esters 29 and 30
A mixture of mercaptotriazole 25 or 26 (2 mmol), ethyl bromoacetate (334 mg, 2 mmol), and anh. K 2 CO 3 (552 mg, 4 mmol) in 2-butanone (10 mL) was heated at reflux temperature for 6 h. The mixture was cooled to room temperature, and the solid was filtered and washed with 2-butanone (2 ×10 mL). The combined filtrate was processed as described in each case. 
5-Methylthio-4-phenyl-3-[4-(1H -pyrrol-1-yl)phenyl]-4H -1,2,4-triazole (31)
A mixture of 4-phenyl-3-[4-(1H -pyrrol-1-yl)phenyl]-1H -1,2,4-triazole-5-thione (24) (318 mg, 1 mmol) and KOH (99 mg, 1.5 mmol, 85% purity) in 96% ethanol (8 mL) was heated at reflux temperature for 10 min; then iodomethane (568 mg, 4 mmol) in 96% ethanol (2 mL) was added and the resulting mixture was heated at reflux temperature for 1 h. The cold reaction mixture was gradually diluted with water (40 mL) under efficient stirring. The separated solid was filtered, washed with water, air dried, and recrystallized from 2-butanone to give yellow crystals (232 mg, 70%), mp 228-229°C; 
General procedure for the synthesis of thioethers 32-35
To the solution obtained from mercaptotriazole (1 mmol) and KOH (66 mg, 1 mmol, 85% purity) in 96% ethanol (5 mL) was added the alkylating agent (1 mmol) and the mixture was heated at reflux temperature for 1 h.
The cooled reaction mixture was gradually diluted with water (40 mL) under efficient stirring. 
General procedure for the synthesis of Mannich bases 36 and 37
A mixture of mercaptotriazole (2 mmol), aq. 37% formaldehyde (240 mg, 3 mmol), and cyclic secondary amine (3 mmol) in 96% ethanol (5 mL) was heated at reflux temperature for 1 h. The mixture was refrigerated for 2 days and the resulting solid was filtered and air dried. The solid was redissolved in hot ethanol (5 mL) and water was added dropwise until a slight turbidity was ob- 
Biological activity
Evaluation of the antimycobacterial activity was performed according to CLSI M24-A2 standard, a broth microdilution method that allows the determination of MIC for a given substance against different mycobacteria. 
